Future of Executive Summary Asia-Pacific Viral Vector Purification Market: Size and Share Dynamics CAGR Value The Asia-Pacific Viral Vector Purification market size was valued at USD 420 billion in 2025 and is expected to reach USD 1132.45 billion by 2033, at a CAGR of 13.20% during the forecast period A DBMR team of experts and professionals from a...

  Financial analysis of the animal model market reveals substantial market valuation with projections indicating continued robust growth driven by pharmaceutical industry expansion, increasing research spending, and growing recognition of preclinical research's critical role in successful therapeutic development. The Animal Model Market Size reflects revenue generated through...

NEWARK, DE | 20 Mar 2026 —The global microfluidic organ-on-chip drug testing market is entering a rapid growth phase as pharmaceutical and biotechnology companies transition from traditional animal and static cell-based assays to dynamic, human-relevant predictive models. Valued at USD 141.5 million in 2025, the market is projected to reach USD 168.0 million in 2026 and surge to USD 932.9...

NEWARK, DE | The Microfluidic Organ-on-Chip Drug Testing Market is poised for rapid expansion, rising from USD 141.5 million in 2025 to USD 932.9 million by 2036, advancing at a CAGR of 18.70%. With the market valued at USD 168.0 million in 2026, the shift toward human-relevant, predictive preclinical models is redefining drug development workflows and accelerating the replacement of...

The Global Analytical Laboratory Services Market is poised for substantial growth over the next decade, driven by rising demand for testing and analysis across pharmaceuticals, biotechnology, food & beverages, environmental sectors, and healthcare diagnostics. Analytical laboratory services encompass a range of functions such as chemical analysis, biological testing, material...